Visioneering Technologies (ASX:VTI) Announces Positive Interim Data
Promising Year 2 Findings
Visioneering Technologies Inc. (ASX:VTI) has announced encouraging preliminary findings from year two of the PROTECT clinical trial. The trial assesses the safety and effectiveness of the NaturalVue Multifocal 1 Day contact lenses in managing myopia progression in children. The latest data indicates a significant reduction in myopia progression, with a 0.60 D decrease in refractive error and a 0.25 mm reduction in axial length compared to the control group.
Study Design and Robust Outcomes
The PROTECT study is a three-year, multicenter, randomized, double-masked clinical trial adhering to stringent scientific protocols. These results align with the treatment effects seen in the only FDA-approved therapy for myopia control. Low dropout rates highlight the comfort and vision performance of the NaturalVue lenses.
Future Outlook
Dr. Ashley Tuan, VTI’s Chief Medical Officer, will present these findings at the Global Specialty Lens Symposium. VTI commits to sharing more details as the study progresses and anticipates the release of more comprehensive two-year and three-year data in the future. The ongoing commitment to analysing these findings underscores VTI’s dedication to tackling myopia among children.
About Visioneering Technologies
Visioneering Technologies, Inc. is focused on transforming vision care, especially in presbyopia and myopia management. Its flagship product, the NaturalVue Multifocal 1 Day Contact Lens, is regarded as a significant innovation in the eye care industry.
Motley Fool contributor Aaron Shaw has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.